These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38416270)

  • 1. Real-world use and clinical impact of an electronic patient-reported outcome tool in patients with solid tumors treated with immuno-oncology therapy.
    Dickson NR; Beauchamp KD; Perry TS; Roush A; Goldschmidt D; Edwards ML; Blakely LJ
    J Patient Rep Outcomes; 2024 Feb; 8(1):23. PubMed ID: 38416270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing Symptom Management Follow-up Using an Electronic Patient-Reported Outcome Platform in Outpatients With Advanced Cancer: Longitudinal Single-Center Prospective Study.
    Tang L; He Y; Pang Y; Su Z; Li J; Zhang Y; Wang X; Han X; Wang Y; Li Z; He S; Song L; Zhou Y; Wang B; Li X
    JMIR Form Res; 2022 May; 6(5):e21458. PubMed ID: 35536608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of Electronic Patient-Reported Outcomes for Symptom Monitoring in a Large Multisite Community Oncology Practice: Dancing the Texas Two-Step Through a Pandemic.
    Patt D; Wilfong L; Hudson KE; Patel A; Books H; Pearson B; Boren R; Patil S; Olson-Celli K; Basch E
    JCO Clin Cancer Inform; 2021 May; 5():615-621. PubMed ID: 34085537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usability of Electronic Patient-Reported Outcome Measures for Older Patients With Cancer: Secondary Analysis of Data from an Observational Single Center Study.
    Riedl D; Lehmann J; Rothmund M; Dejaco D; Grote V; Fischer MJ; Rumpold G; Holzner B; Licht T
    J Med Internet Res; 2023 Sep; 25():e49476. PubMed ID: 37733409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment patterns and clinical outcomes in patients with advanced non-small cell lung cancer initiating first-line treatment in the US community oncology setting: a real-world retrospective observational study.
    Nadler E; Arondekar B; Aguilar KM; Zhou J; Chang J; Zhang X; Pawar V
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):671-690. PubMed ID: 33263865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal study of symptom burden in outpatients with advanced cancers based on electronic Patient-Reported Outcome (ePRO) platform: a single institution, prospective study protocol.
    Tang L; Pang Y; He Y; Shi Q; Han X; Li Z; Zhou C; Zhou Y; He S; Wang Y; Zhang Y; Song L; Wang B; Li X
    BMJ Open; 2020 Nov; 10(11):e038223. PubMed ID: 33444183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A real-time electronic symptom monitoring system for patients after discharge following surgery: a pilot study in cancer-related surgery.
    Richards HS; Blazeby JM; Portal A; Harding R; Reed T; Lander T; Chalmers KA; Carter R; Singhal R; Absolom K; Velikova G; Avery KNL
    BMC Cancer; 2020 Jun; 20(1):543. PubMed ID: 32522163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficiency of Electronic Health Record Assessment of Patient-Reported Outcomes After Cancer Immunotherapy: A Randomized Clinical Trial.
    Zhang L; Zhang X; Shen L; Zhu D; Ma S; Cong L
    JAMA Netw Open; 2022 Mar; 5(3):e224427. PubMed ID: 35357459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-World Clinical Outcomes in Patients with Locally Advanced or Metastatic Merkel Cell Carcinoma Treated in U.S. Oncology Clinical Practices: Results from SPEAR-Merkel.
    Bhanegaonkar A; Liu FX; Boyd M; Fulcher N; Kim R; Krulewicz S; Smith J; Cowey CL
    Oncologist; 2021 Sep; 26(9):e1633-e1643. PubMed ID: 34101298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ePROs in the follow-up of cancer patients treated with immune checkpoint inhibitors: a retrospective study.
    Iivanainen S; Alanko T; Peltola K; Konkola T; Ekström J; Virtanen H; Koivunen JP
    J Cancer Res Clin Oncol; 2019 Mar; 145(3):765-774. PubMed ID: 30666409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and usability testing of an electronic patient-reported outcome (ePRO) solution for patients with inflammatory diseases in an Advanced Therapy Medicinal Product (ATMP) basket trial.
    McMullan C; Retzer A; Hughes SE; Aiyegbusi OL; Bathurst C; Boyd A; Coleman J; Davies EH; Denniston AK; Dunster H; Frost C; Harding R; Hunn A; Kyte D; Malpass R; McNamara G; Mitchell S; Mittal S; Newsome PN; Price G; Rowe A; van Reil W; Walker A; Wilson R; Calvert M
    J Patient Rep Outcomes; 2023 Oct; 7(1):98. PubMed ID: 37812323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FRACTION-RCC: nivolumab plus ipilimumab for advanced renal cell carcinoma after progression on immuno-oncology therapy.
    Choueiri TK; Kluger H; George S; Tykodi SS; Kuzel TM; Perets R; Nair S; Procopio G; Carducci MA; Castonguay V; Folefac E; Lee CH; Hotte SJ; Miller WH; Saggi SS; Lee CW; Desilva H; Bhagavatheeswaran P; Motzer RJ; Escudier B
    J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36328377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?
    Santoni M; Buti S; Myint ZW; Maruzzo M; Iacovelli R; Pichler M; Kopecky J; Kucharz J; Rizzo M; Galli L; Büttner T; De Giorgi U; Kanesvaran R; Fiala O; Grande E; Zucali PA; Kopp RM; Fornarini G; Bourlon MT; Scagliarini S; Molina-Cerrillo J; Aurilio G; Matrana MR; Pichler R; Cattrini C; Büchler T; Massari F; Seront E; Calabrò F; Pinto A; Berardi R; Zgura A; Mammone G; Ansari J; Atzori F; Chiari R; Bamias A; Caffo O; Procopio G; Sunela K; Bassanelli M; Ortega C; Grillone F; Landmesser J; Milella M; Messina C; Küronya Z; Mosca A; Bhuva D; Santini D; Vau N; Morelli F; Incorvaia L; Rebuzzi SE; Roviello G; Soares A; Bisonni R; Bimbatti D; Zabalza IO; Rizzo A; Mollica V; Sorgentoni G; Monteiro FSM; Battelli N; Bracarda S; Porta C
    Eur Urol Oncol; 2024 Feb; 7(1):102-111. PubMed ID: 37481365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-World Costs of Adverse Events in First-Line Treatment of Metastatic Non-Small Cell Lung Cancer.
    Engel-Nitz NM; Johnson MP; Bunner SH; Ryan KJ
    J Manag Care Spec Pharm; 2020 Jun; 26(6):729-740. PubMed ID: 32463768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of symptom management interventions based on electronic patient-reported outcomes (ePROs) for symptom burden, quality of life, and overall survival among patients with cancer: A meta-analysis of randomized controlled trials.
    Li Y; Li J; Hu X
    Int J Nurs Stud; 2023 Nov; 147():104588. PubMed ID: 37690275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-World Use of Electronic Patient-Reported Outcome (ePRO) Tools Integrated in the Electronic Medical Record During Radiation Therapy for Head and Neck Cancer: Feasibility Study.
    Katzel JA; Van Den Eeden SK; Liu R; Leimpeter A; Briones CB; Lewis DL; Lee-Enriquez NM; Patel M; Patel D; Gillis A; Yan J; Kaufman MA; Altschuler A; Shan J; Basch E
    Perm J; 2023 Sep; 27(3):60-67. PubMed ID: 37635460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy After Immuno-oncology Checkpoint Inhibitors.
    Graham J; Shah AY; Wells JC; McKay RR; Vaishampayan U; Hansen A; Donskov F; Bjarnason GA; Beuselinck B; De Velasco G; Iafolla M; Duh MS; Huynh L; Chang R; Zanotti G; Ramaswamy K; Choueiri TK; Tannir NM; Heng DYC
    Eur Urol Oncol; 2021 Feb; 4(1):102-111. PubMed ID: 31786162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of patient-reported outcomes for symptom management in oncology practice through the SIMPRO research consortium: a protocol for a pragmatic type II hybrid effectiveness-implementation multi-center cluster-randomized stepped wedge trial.
    Hassett MJ; Wong S; Osarogiagbon RU; Bian J; Dizon DS; Jenkins HH; Uno H; Cronin C; Schrag D;
    Trials; 2022 Jun; 23(1):506. PubMed ID: 35710449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Real-World Treatment Patterns and Clinical Outcomes in Patients with Metastatic Breast Cancer Treated with Eribulin After Prior Immuno-Oncology or Antibody-Drug Conjugate Therapy.
    Goyal RK; Zhang J; Davis KL; Sluga-O'Callaghan M; Kaufman PA
    Breast Cancer (Dove Med Press); 2023; 15():855-865. PubMed ID: 38020049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.